BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: [DOI: 10.1101/2020.02.03.931766] [Cited by in Crossref: 286] [Cited by in F6Publishing: 78] [Reference Citation Analysis]
Number Citing Articles
1 Cherradi Y. CoVID-19: a Digestive Disease! JMSR. [DOI: 10.46327/msrjg.1.000000000000159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Miri SM, Roozbeh F, Omranirad A, Alavian SM. Panic of Buying Toilet Papers: A Historical Memory or a Horrible Truth? Systematic Review of Gastrointestinal Manifestations of COVID-19. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.102729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
3 Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther 2020;5:256. [PMID: 33139693 DOI: 10.1038/s41392-020-00373-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
4 Lin H, Wu LJ, Guo SQ, Chen RL, Fan JR, Ke B, Pan ZQ. Dynamic monitoring of serum liver function indexes in patients with COVID-19. World J Clin Cases 2021; 9(7): 1554-1562 [PMID: 33728299 DOI: 10.12998/wjcc.v9.i7.1554] [Reference Citation Analysis]
5 Klhůfek J. The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero? Acta Clinica Belgica. [DOI: 10.1080/17843286.2020.1786324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ciaccio M, Agnello L. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis (Berl) 2020;7:365-72. [PMID: 32589600 DOI: 10.1515/dx-2020-0057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
7 Taneja S, Mehtani R, Chawla YK. Gastrointestinal and Liver Manifestations of COVID-19. Annals of the National Academy of Medical Sciences (India) 2020;56:091-8. [DOI: 10.1055/s-0040-1713837] [Reference Citation Analysis]
8 [DOI: 10.1101/2020.04.19.049254] [Cited by in Crossref: 93] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
9 Rehman H, Ahmad MI. COVID-19: a wreak havoc across the globe. Arch Physiol Biochem 2020;:1-13. [PMID: 32730095 DOI: 10.1080/13813455.2020.1797105] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 [DOI: 10.1101/2020.02.17.20024018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
11 Verma HK, Bhaskar L. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted. World J Gastroenterol 2021; 27(45): 7855-7858 [PMID: 34963747 DOI: 10.3748/wjg.v27.i45.7855] [Reference Citation Analysis]
12 Arnstadt B, Zillinger C, Treitl M, Allescher HD. Corona again? SSC after a severe COVID-disease. Z Gastroenterol 2021. [PMID: 34666402 DOI: 10.1055/a-1647-3785] [Reference Citation Analysis]
13 Perveen N, Muzaffar SB, Al-Deeb MA. Exploring human-animal host interactions and emergence of COVID-19: Evolutionary and ecological dynamics. Saudi J Biol Sci 2021;28:1417-25. [PMID: 33281479 DOI: 10.1016/j.sjbs.2020.11.077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Cha MH, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J Gastroenterol 2020; 26(19): 2323-2332 [PMID: 32476796 DOI: 10.3748/wjg.v26.i19.2323] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 47] [Article Influence: 30.0] [Reference Citation Analysis]
15 Gupta K, Mohanty SK, Mittal A, Kalra S, Kumar S, Mishra T, Ahuja J, Sengupta D, Ahuja G. The Cellular basis of loss of smell in 2019-nCoV-infected individuals. Brief Bioinform 2021;22:873-81. [PMID: 32810867 DOI: 10.1093/bib/bbaa168] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
16 Mnatsakanyan MG, Pogromov AP, Lishuta AS, Fomin VV, Volkova OS, Tashchyan OV, Kuprina IV, Shumskaya YF. Liver and COVID-19: possible mechanisms of damage. Terapevticheskii arkhiv 2021;93:427-30. [DOI: 10.26442/00403660.2021.04.200733] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tian S, Zheng N, Zu X, Wu G, Zhong J, Zhang J, Sheng L, Liu W, Wang C, Ge G, Han J, Zhao J, Li H, Zhang W. Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia. Phytomedicine 2022;97:153922. [PMID: 35032732 DOI: 10.1016/j.phymed.2021.153922] [Reference Citation Analysis]
18 Rehman SU, Tabish M. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs. Clin Sci (Lond) 2020;134:1143-50. [PMID: 32442315 DOI: 10.1042/CS20200419] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
19 Kardani K, Bolhassani A, Kardani M, Agi E; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. JoMMID 2021;9:122-32. [DOI: 10.52547/jommid.9.3.122] [Reference Citation Analysis]
20 Deng ML, Chen YJ, Yang ML, Liu YW, Chen H, Tang XQ, Yang XF. COVID-19 combined with liver injury: Current challenges and management. World J Clin Cases 2021; 9(15): 3487-3497 [PMID: 34046449 DOI: 10.12998/wjcc.v9.i15.3487] [Reference Citation Analysis]
21 Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, Xiao SY. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33:1007-1014. [PMID: 32291399 DOI: 10.1038/s41379-020-0536-x] [Cited by in Crossref: 391] [Cited by in F6Publishing: 375] [Article Influence: 195.5] [Reference Citation Analysis]
22 Hua S, Yang Y, Zou D, Li J, Yan K, Xu Y, Jiang X, Rong X, Ye D. COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies. Biomed Pharmacother 2021;140:111685. [PMID: 34015585 DOI: 10.1016/j.biopha.2021.111685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sikkema BJB, Sint Nicolaas JJ, van Wijngaarden PP. No association between COVID-19 related liver injury and the course of disease: a retrospective study. Scand J Gastroenterol 2021;56:68-71. [PMID: 33119428 DOI: 10.1080/00365521.2020.1842489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 [DOI: 10.1101/2020.03.23.002832] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
25 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Al-Zaidan L, Mestiri S, Raza A, Merhi M, Inchakalody VP, Fernandes Q, Taib N, Uddin S, Dermime S. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Tumour Biol 2021;43:177-96. [PMID: 34420993 DOI: 10.3233/TUB-200084] [Reference Citation Analysis]
28 Kumar V. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us. Int Rev Immunol 2021;40:5-53. [PMID: 32744465 DOI: 10.1080/08830185.2020.1800688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
29 [DOI: 10.1101/2020.04.03.20051722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Baroiu L, Dumitru C, Iancu A, Leșe AC, Drăgănescu M, Baroiu N, Anghel L. COVID-19 impact on the liver. World J Clin Cases 2021; 9(16): 3814-3825 [PMID: 34141738 DOI: 10.12998/wjcc.v9.i16.3814] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 [DOI: 10.1101/2020.03.25.20043703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Maev IV, Shpektor AV, Vasilyeva EY, Manchurov VN, Andreev DN. [Novel coronavirus infection COVID-19: extrapulmonary manifestations]. Ter Arkh 2020;92:4-11. [PMID: 33346454 DOI: 10.26442/00403660.2020.08.000767] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 [DOI: 10.1101/2020.03.13.20035329] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
34 Mirbahari SN, Ahmadi R; Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran, Avicenna International College, Budapest, Hungary. The Effects of COVID-19 from Fertilization until Birth: A Literature Review. PCNM 2020;10:22-33. [DOI: 10.52547/pcnm.10.3.22] [Reference Citation Analysis]
35 Lizardo-thiebaud MJ, Cervantes-alvarez E, Limon-de la Rosa N, Tejeda-dominguez F, Palacios-jimenez M, Méndez-guerrero O, Delaye-martinez M, Rodriguez-alvarez F, Romero-morales B, Liu W, Huang CA, Kershenobich D, Navarro-alvarez N. Direct or Collateral Liver Damage in SARS-CoV-2–Infected Patients. Semin Liver Dis 2020;40:321-30. [DOI: 10.1055/s-0040-1715108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Rahman S, Montero MTV, Rowe K, Kirton R, Kunik F Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 2021;14:601-21. [PMID: 33705239 DOI: 10.1080/17512433.2021.1902303] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Tang YF, Jiang P, Zhang YB, Wang XW, Wang YB, Zhang QY, Teng Y, Yu H, Meng H, Zhang W, Ma Z. Risk factors for COVID-19-related liver injury. Shijie Huaren Xiaohua Zazhi 2020; 28(15): 691-698 [DOI: 10.11569/wcjd.v28.i15.691] [Reference Citation Analysis]
38 Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] [Reference Citation Analysis]
39 Saleem S, Ishtiaq R, Inayat F, Aziz M, Bleibel W. Gastrointestinal and Liver Manifestations in COVID-19 Population. Middle East J Dig Dis 2021;13:281-6. [DOI: 10.34172/mejdd.2021.236] [Reference Citation Analysis]
40 Zhao B, Ni C, Gao R, Wang Y, Yang L, Wei J, Lv T, Liang J, Zhang Q, Xu W, Xie Y, Wang X, Yuan Z, Liang J, Zhang R, Lin X. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell 2020;11:771-5. [PMID: 32303993 DOI: 10.1007/s13238-020-00718-6] [Cited by in Crossref: 100] [Cited by in F6Publishing: 122] [Article Influence: 50.0] [Reference Citation Analysis]
41 Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, Li Z, Cui X, Xiao J, Zhan J, Meng T, Zhou W, Liu J, Xu H. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut 2020;69:1010-8. [DOI: 10.1136/gutjnl-2020-320953] [Cited by in Crossref: 196] [Cited by in F6Publishing: 51] [Article Influence: 98.0] [Reference Citation Analysis]
42 Fu C, Yao X, Zhang S, Dai C, Jian T, Du B, Li P, Jiang Z. High-pressure in situ methods revealing the effect of pressure on glutathione structure. Food Chem 2021;359:129808. [PMID: 33940470 DOI: 10.1016/j.foodchem.2021.129808] [Reference Citation Analysis]
43 Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases 2021; 9(3): 528-539 [PMID: 33553391 DOI: 10.12998/wjcc.v9.i3.528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
44 Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
45 Kaviani M, Keshtkar S, Soleimanian S, Sabet Sarvestani F, Azarpira N, Pakbaz S. Susceptibility to Metabolic Diseases in COVID-19: To be or Not to be an Issue. Front Mol Biosci 2022;9:803314. [DOI: 10.3389/fmolb.2022.803314] [Reference Citation Analysis]
46 Zhang H, Liao YS, Gong J, Liu J, Zhang H. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan. World J Gastroenterol 2020; 26(31): 4694-4702 [PMID: 32884226 DOI: 10.3748/wjg.v26.i31.4694] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 [DOI: 10.1101/2020.02.28.20029025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
48 Olaniyan OT, Dare A, Okotie GE, Adetunji CO, Ibitoye BO, Bamidele OJ, Eweoya OO. Testis and blood-testis barrier in Covid-19 infestation: role of angiotensin-converting enzyme 2 in male infertility. J Basic Clin Physiol Pharmacol 2020;31. [PMID: 33006953 DOI: 10.1515/jbcpp-2020-0156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
49 Gupta T. COVID-19 and liver disease: Are we missing something? World J Hepatol 2022;14:479-81. [PMID: 35317182 DOI: 10.4254/wjh.v14.i2.479] [Reference Citation Analysis]
50 Funt SA, Cohen SL, Wang JJ, Sanelli PC, Barish MA. Abdominal pelvic CT findings compared between COVID-19 positive and COVID-19 negative patients in the emergency department setting. Abdom Radiol (NY). 2021;46:1498-1505. [PMID: 33044654 DOI: 10.1007/s00261-020-02796-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Liao X, Li D, Ma Z, Zhang L, Zheng B, Li Z, Li G, Liu L, Zhang Z. 12-Month Post-Discharge Liver Function Test Abnormalities Among Patients With COVID-19: A Single-Center Prospective Cohort Study. Front Cell Infect Microbiol 2022;12:864933. [DOI: 10.3389/fcimb.2022.864933] [Reference Citation Analysis]
52 Huang YK, Li YJ, Li B, Wang P, Wang QH. Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives. World J Gastroenterol 2021; 27(27): 4358-4370 [PMID: 34366609 DOI: 10.3748/wjg.v27.i27.4358] [Reference Citation Analysis]
53 Brumeanu TD, Vir P, Karim AF, Kar S, Benetiene D, Lok M, Greenhouse J, Putmon-Taylor T, Kitajewski C, Chung KK, Pratt KP, Casares SA. A Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO.IL-2Rγc KO. NOD) for COVID-19. bioRxiv 2021:2020. [PMID: 32839773 DOI: 10.1101/2020.08.19.251249] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Torres Mesa PA. Endoscopia digestiva en tiempos de covid-19: Resumen de recomendaciones. Rev Colomb Cir 2020;35:209-15. [DOI: 10.30944/20117582.622] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Omrani-nava V, Maleki I, Ahmadi A, Moosazadeh M, Hedayatizadeh-omran A, Roozbeh F, Nahanghi H, Alizadeh-navaei R. Evaluation of Hepatic Enzymes Changes and Association with Prognosis in COVID-19 Patients. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.103179] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
56 Chen LP, Zeng QH, Gong YF, Liang FL. Should people with chronic liver diseases be vaccinated against COVID-19? World J Clin Cases 2021; 9(26): 7959-7962 [PMID: 34621852 DOI: 10.12998/wjcc.v9.i26.7959] [Reference Citation Analysis]
57 Neuman MG, Seitz HK, Teschke R, Malnick S, Johnson-davis KL, Cohen LB, German A, Hohmann N, Moreira B, Moussa G, Opris M. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury. CIMB 2022;44:1294-315. [DOI: 10.3390/cimb44030087] [Reference Citation Analysis]
58 Mohammed SA, Eid KM, Anyiam FE, Wadaaallah H, Muhamed MAM, Morsi MH, Dahman NBH. Liver injury with COVID-19: laboratory and histopathological outcome—systematic review and meta-analysis. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00171-6] [Reference Citation Analysis]
59 Chela HK, Pasha SB, Basar O, Daglilar E, Tahan V. Liver in the limelight in the corona (COVID-19) time. World J Clin Cases 2020; 8(16): 3405-3410 [PMID: 32913847 DOI: 10.12998/wjcc.v8.i16.3405] [Reference Citation Analysis]
60 [DOI: 10.1101/2020.02.08.939892] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
61 Gabrielli M, Franza L, Esperide A, Gasparrini I, Gasbarrini A, Franceschi F; on behalf of GEMELLI AGAINST COVID 2019. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy. Vaccines 2022;10:192. [DOI: 10.3390/vaccines10020192] [Reference Citation Analysis]
62 Zhao JN, Fan Y, Wu SD. Liver injury in COVID-19: A minireview. World J Clin Cases 2020; 8(19): 4303-4310 [PMID: 33083389 DOI: 10.12998/wjcc.v8.i19.4303] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
63 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 [DOI: 10.1101/2020.04.06.028522] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
65 Jakubiak GK, Ochab-jakubiak J, Cieślar G, Stanek A. Gastrointestinal symptoms in the course of COVID-19. Postepy Hig Med Dosw 2020;74:498-503. [DOI: 10.5604/01.3001.0014.5459] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Baroiu L, Lese AC, Stefanopol IA, Iancu A, Dumitru C, Ciubara AB, Bujoreanu FC, Baroiu N, Ciubara A, Nechifor A, Anghel L, Tatu AL. The Role of D-Dimers in the Initial Evaluation of COVID-19. TCRM 2022;Volume 18:323-35. [DOI: 10.2147/tcrm.s357214] [Reference Citation Analysis]
67 Krishnan A, Prichett L, Tao X, Alqahtani SA, Hamilton JP, Mezey E, Strauss AT, Kim A, Potter JJ, Chen PH, Woreta TA. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients. World J Gastroenterol 2022; 28(5): 570-587 [DOI: 10.3748/wjg.v28.i5.570] [Reference Citation Analysis]
68 [DOI: 10.1101/2020.06.04.20122457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Reference Citation Analysis]
70 Roy HS, Singh R, Ghosh D. SARS-CoV-2 and tissue damage: current insights and biomaterial-based therapeutic strategies. Biomater Sci 2021;9:2804-24. [PMID: 33666206 DOI: 10.1039/d0bm02077j] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Vitiello A, La Porta R, Ferrara F. Correlation between the use of statins and COVID-19: what do we know? BMJ Evid Based Med 2020:bmjebm-2020-111589. [PMID: 33268349 DOI: 10.1136/bmjebm-2020-111589] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
72 Suresh Kumar VC, Harne PS, Mukherjee S, Gupta K, Masood U, Sharma AV, Lamichhane J, Dhamoon AS, Sapkota B. Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study. World J Hepatol 2020; 12(9): 619-627 [PMID: 33033568 DOI: 10.4254/wjh.v12.i9.619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Srivastava S, Garg I. Post COVID-19 infection: Long-term effects on liver and kidneys. World J Meta-Anal 2021; 9(3): 220-233 [DOI: 10.13105/wjma.v9.i3.220] [Reference Citation Analysis]
74 Zhang SS, Dong L, Wang GM, Tian Y, Ye XF, Zhao Y, Liu ZY, Zhai JY, Zhao ZL, Wang JH, Zhang HM, Li XL, Wu CX, Yang CT, Yang LJ, Du HX, Wang H, Ge QG, Xiu DR, Shen N. Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China. World J Gastroenterol 2021; 27(9): 835-853 [PMID: 33727773 DOI: 10.3748/wjg.v27.i9.835] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Weber S, Mayerle J, Irlbeck M, Gerbes AL. Severe liver failure during SARS-CoV-2 infection. Gut. 2020;69:1365-1367. [PMID: 32327526 DOI: 10.1136/gutjnl-2020-321350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
76 Haybar H, Kazemnia K, Rahim F. Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review. Jundishapur J Chronic Dis Care 2020;9. [DOI: 10.5812/jjcdc.103452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
77 Ong J, Young BE, Ong S. COVID-19 in gastroenterology: a clinical perspective. Gut. 2020;69:1144-1145. [PMID: 32198152 DOI: 10.1136/gutjnl-2020-321051] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 31.5] [Reference Citation Analysis]
78 Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: Etiology, treatment and prognosis. World J Gastroenterol 2020;26:2286-93. [PMID: 32476793 DOI: 10.3748/wjg.v26.i19.2286] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 46] [Article Influence: 29.5] [Reference Citation Analysis]
79 [DOI: 10.1101/2020.09.03.280727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
81 Liu R, Zhao L, Cheng X, Han H, Li C, Li D, Liu A, Gao G, Zhou F, Liu F, Jiang Y, Zhu C, Xia Y. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study. Liver Int. 2021;41:720-730. [PMID: 33351265 DOI: 10.1111/liv.14774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
82 Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, Makvandi P. Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside. ACS Biomater Sci Eng 2021;7:2150-76. [PMID: 33979143 DOI: 10.1021/acsbiomaterials.1c00318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Kakos CD, Ziogas IA, Tsoulfas G. Pediatric transplantation during the COVID-19 pandemic. World J Transplant 2022; 12(5): 88-99 [DOI: 10.5500/wjt.v12.i5.88] [Reference Citation Analysis]
84 Yazdanpanah F, Garg A, Shadman S, Asmarz HY. Literature Review of COVID-19, Pulmonary and Extrapulmonary Disease. Am J Med Sci 2021;361:567-74. [PMID: 33785204 DOI: 10.1016/j.amjms.2021.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 [DOI: 10.1101/2020.03.21.20037267] [Cited by in Crossref: 104] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
86 Xiang D, Ren X, Chen Q, Yu H, Li X, Liu D. Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19. Clin Exp Hypertens 2021;43:305-10. [PMID: 33356606 DOI: 10.1080/10641963.2020.1867160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Pei L, Zhang M, Kuniya T. Long-Term Predictions of COVID-19 in Some Countries by the SIRD Model. Complexity 2021;2021:1-18. [DOI: 10.1155/2021/6692678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Otero Regino W, Gómez Zuleta MA, Angel Arango LA, Ruíz Morales OF, Marulanda Fernández H, Riveros J, Junca Burgos EG, Ballén Parraga H, Rodríguez A, Pineda Ovalle LF, Otero Ramos EB, Otero Parra L, Jaramillo T G, Buitrago J, Rodríguez J, Bastidas M. Procedimientos endoscópicos y pandemia COVID19. Consideraciones básicas. Rev Colomb Gastroenterol 2020;35:65-75. [DOI: 10.22516/25007440.526] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
89 Deshmukh V, Motwani R, Kumar A, Kumari C, Raza K. Histopathological observations in COVID-19: a systematic review. J Clin Pathol. 2021;74:76-83. [PMID: 32817204 DOI: 10.1136/jclinpath-2020-206995] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 18.5] [Reference Citation Analysis]
90 Saini RK, Saini N, Ram S, Soni SL, Suri V, Malhotra P, Kaur J, Verma I, Sharma S, Zohmangaihi D. COVID-19 associated variations in liver function parameters: a retrospective study. Postgrad Med J. 2020;. [PMID: 33184141 DOI: 10.1136/postgradmedj-2020-138930] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
91 Teodorescu M. An Overview of a Year with COVID-19: What We Know? ELECTRON J GEN MED 2021;18:em286. [DOI: 10.29333/ejgm/9765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Cococcia S, Lenti MV, Santacroce G, Achilli G, Borrelli de Andreis F, Di Sabatino A. Liver-spleen axis dysfunction in COVID-19. World J Gastroenterol 2021; 27(35): 5919-5931 [PMID: 34629809 DOI: 10.3748/wjg.v27.i35.5919] [Reference Citation Analysis]
93 Lui VC, Hui KP, Babu RO, Yue H, Chung PH, Tam PK, Chan MC, Wong KK. Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-09306-6] [Reference Citation Analysis]
94 Reyes AZ, Hu KA, Teperman J, Wampler Muskardin TL, Tardif JC, Shah B, Pillinger MH. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine. Ann Rheum Dis 2021;80:550-7. [PMID: 33293273 DOI: 10.1136/annrheumdis-2020-219174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
95 [DOI: 10.1101/2020.02.28.20028514] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
96 [DOI: 10.1101/2020.02.16.951913] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
97 Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 [PMID: 34366621 DOI: 10.3748/wjg.v27.i28.4504] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Chu X, Zhang GF, Zheng YK, Zhong YG, Wen L, Zeng P, Fu CY, Tong XL, Long YF, Li J, Liu YL, Chang ZG, Xi H. Clinical features and risk factors of severely and critically ill patients with COVID-19. World J Clin Cases 2022; 10(3): 840-855 [DOI: 10.12998/wjcc.v10.i3.840] [Reference Citation Analysis]
99 [DOI: 10.1101/2020.02.12.20022418] [Cited by in Crossref: 138] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
100 Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021; 13(9): 1143-1153 [PMID: 34630881 DOI: 10.4254/wjh.v13.i9.1143] [Reference Citation Analysis]
101 Lima FB, Bezerra KC, Nascimento JCR, Meneses GC, Oriá RB. Risk Factors for Severe COVID-19 and Hepatitis C Infections: The Dual Role of Apolipoprotein E4. Front Immunol 2022;13:721793. [DOI: 10.3389/fimmu.2022.721793] [Reference Citation Analysis]
102 Ye L, Yang Z, Liu J, Liao L, Wang F. Digestive system manifestations and clinical significance of coronavirus disease 2019: A systematic literature review. J Gastroenterol Hepatol. 2020;. [PMID: 33150978 DOI: 10.1111/jgh.15323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
103 Wang J, Zhu L, Xue L, Liu L, Yan X, Huang S, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Cheng J, Shao H, Chen K, Zhao XA, Sang D, Zhao H, Guan X, Chen X, Chen Y, Liu J, Huang R, Zhu C, Wu C. Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi-center study. J Med Virol. 2020;. [PMID: 33174624 DOI: 10.1002/jmv.26663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Shao J, Liang Y, Li Y, Ding R, Zhu M, You W, Wang Z, Huang B, Wu M, Zhang T, Li K, Wu W, Wu L, Wang Q, Xia X, Wang S, Lu L. Implications of liver injury in risk-stratification and management of patients with COVID-19. Hepatol Int. 2021;15:202-212. [PMID: 33548030 DOI: 10.1007/s12072-020-10123-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
105 Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12:8. [PMID: 32094336 DOI: 10.1038/s41368-020-0074-x] [Cited by in Crossref: 1039] [Cited by in F6Publishing: 979] [Article Influence: 519.5] [Reference Citation Analysis]
106 Ozkurt Z, Çınar Tanrıverdi E. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World J Clin Cases 2022; 10(4): 1140-1163 [DOI: 10.12998/wjcc.v10.i4.1140] [Reference Citation Analysis]
107 Dadkhah M, Talei S, Doostkamel D, Molaei S, Rezaei N. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review. Rev Neurosci 2021. [PMID: 34087964 DOI: 10.1515/revneuro-2020-0154] [Reference Citation Analysis]